openPR Logo
Press release

Metabolic Acidosis Market Size is estimated to grow with a significant CAGR by 2034, estimates DelveInsight

11-18-2024 10:14 PM CET | Health & Medicine

Press release from: ABNewswire

Metabolic Acidosis Market Size is estimated to grow with

Metabolic Acidosis Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition.

DelveInsight's "Metabolic Acidosis Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Metabolic Acidosis, historical and forecasted epidemiology as well as the Metabolic Acidosis market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Discover Key Insights into the Metabolic Acidosis Market with DelveInsight's In-Depth Report @ Metabolic Acidosis Market Size [https://www.delveinsight.com/sample-request/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Metabolic Acidosis Market Report

* In November 2024:- Tisento Therapeutics- The PRIZM study is evaluating 2 dose levels of zagociguat in a crossover design consisting of two 12-week treatment periods separated by a 4-week washout. Patients will be screened and if eligible, randomly assigned either to receive placebo in period 1 followed by active drug in period 2 OR to receive active drug in period 1 followed by placebo in period 2.
* In 2023, approximately 1.7 million prevalent cases of metabolic acidosis were diagnosed across the seven major markets (7MM). Of these, around 850,000 cases in the United States were linked to metabolic acidosis in patients with chronic kidney disease (CKD) stages 3 to 5, while the remaining cases were associated with diagnosed cases of distal renal tubular acidosis (dRTA), both inherited and acquired.
* A significant number of metabolic acidosis cases were observed in males, accounting for approximately 55% of the total cases. This higher prevalence in males is due to a greater incidence of underlying conditions such as chronic kidney disease and diabetes, which are more common in men and are major contributors to the development of metabolic acidosis.
* In 2023, treated cases of distal renal tubular acidosis (dRTA), both inherited and acquired, represented less than 1.5% of all treated metabolic acidosis cases in the United States. This is attributed to the relative rarity of dRTA as a cause of metabolic acidosis, especially when compared to more prevalent conditions such as diabetic ketoacidosis and lactic acidosis.
* The leading Metabolic Acidosis Companies such as Tricida, Advicenne Pharma, Thiogenesis Therapeutics, Inc., Tisento Therapeutics, ModernaTX, and others.
* Promising Metabolic Acidosis Therapies such as TTI-0102, Zagociguat 15mg, mRNA-3705, Sonlicromanol, and others.

Stay ahead in the Metabolic Acidosis Therapeutics Market with DelveInsight's Strategic Report @ Metabolic Acidosis Market Outlook [https://www.delveinsight.com/sample-request/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Metabolic Acidosis Epidemiology Segmentation in the 7MM

* Total Prevalence of Chronic Kidney Disorder Patients
* Total Prevalence of Metabolic Acidosis in Chronic Kidney Disorder Patients
* Total Prevalent Cases of Metabolic Acidosis
* Total Prevalent Population of Distal Renal Tubular Acidosis
* Total Diagnosed Population
* Gender-specific diagnosed cases

Download the report to understand which factors are driving Metabolic Acidosis epidemiology trends @ Metabolic Acidosis Prevalence [https://www.delveinsight.com/sample-request/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Metabolic Acidosis Emerging Drugs

Zagociguat: Tisento Therapeutics

Zagociguat is an investigational medicine that is taken as a once-a-day oral tablet. Zagociguat has been studied in 5 clinical trials, including a Phase IIa trial in participants with MELAS. It acts as a potent stimulator of sGC, enhancing the production of cyclic GMP (cGMP) in response to nitric oxide. This pathway plays a crucial role in regulating vascular tone and reducing inflammation.

Metabolic Acidosis Market Outlook

The metabolic acidosis market presents a diverse landscape across the major global markets, reflecting varying levels of demand and healthcare infrastructure. In 2023, the market for metabolic acidosis therapies exhibited significant disparities in size and growth potential among the seven major markets (7MM). In 2023, The United States emerged as the largest market by far, capturing approximately USD 117.6 million, while Europe, including Germany, France, Italy, Spain, and the UK, showcased a range of market sizes.

Get In-Depth Knowledge on Metabolic Acidosis Market Trends and Forecasts with DelveInsight @ Metabolic Acidosis Treatment Market [https://www.delveinsight.com/sample-request/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Scope of the Metabolic Acidosis Market Report

* Coverage- 7MM
* Metabolic Acidosis Companies- Tricida, Advicenne Pharma, Thiogenesis Therapeutics, Inc., Tisento Therapeutics, ModernaTX, and others.
* Metabolic Acidosis Therapies- TTI-0102, Zagociguat 15mg, mRNA-3705, Sonlicromanol, and others..
* Metabolic Acidosis Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Metabolic Acidosis Unmet Needs, KOL's views, Analyst's views, Metabolic Acidosis Market Access and Reimbursement

Unlock Strategic Insights with DelveInsight's Comprehensive Metabolic Acidosis Market Report @ Metabolic Acidosis Market Drivers and Barriers [https://www.delveinsight.com/sample-request/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Table of Content

1. Key Insights

2. Report Introduction

3. Metabolic Acidosis Market Overview at a Glance

4. Methodology

5. Executive Summary

6. Disease Background and Overview

7. Diagnosis

8. Treatment of metabolic acidosis

9. Diagnostic and Treatment Guidelines for Metabolic Acidosis

10. Conclusion

11. Epidemiology and Patient Population

12. Patient Journey

13. Emerging Therapies

14. Market Analysis

15. KOL Views

16. Market Barriers

17. Market Drivers

18. SWOT Analysis

19. Unmet Needs

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=metabolic-acidosis-market-size-is-estimated-to-grow-with-a-significant-cagr-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolic Acidosis Market Size is estimated to grow with a significant CAGR by 2034, estimates DelveInsight here

News-ID: 3742243 • Views:

More Releases from ABNewswire

Total Joy Homecare Responds to Surging Demand for Senior Health Care Services in Greater Houston
Total Joy Homecare Responds to Surging Demand for Senior Health Care Services in …
Total Joy Homecare expands services to meet growing Houston demand for in-home senior care, offering non-medical support that helps families maintain independence and dignity at home. Houston's rapidly aging demographic has prompted local care provider Total Joy Homecare to expand its comprehensive support services, addressing the critical need for quality senior health care services [https://maps.app.goo.gl/hUcW1N7qWy5EdHJs5] throughout the Greater Houston area. The company's response comes as families increasingly seek reliable alternatives to
Texas Company Introduces On-Site Carrier Repair Services to Reduce Fleet Downtime
Texas Company Introduces On-Site Carrier Repair Services to Reduce Fleet Downtim …
Texas Reefer Solutions introduces mobile carrier repair services in Dallas, revolutionizing how transportation fleets handle refrigeration breakdowns by providing on-site professional repairs, eliminating route deviations, and reducing cargo-threatening delays. The transportation industry faces a significant challenge when refrigerated trucks require repairs, often forcing drivers to deviate from critical routes and schedules. Texas Reefer Solutions has emerged as a game-changing solution, introducing mobile carrier repair services [https://maps.app.goo.gl/P6nfg5WF7sckR7aZ8] that bring professional technicians directly
Family Therapy in Birmingham: How the Right Therapist Can Transform Relationships
Family Therapy in Birmingham: How the Right Therapist Can Transform Relationship …
Family therapy in Birmingham helps families improve communication, resolve conflict, and build stronger bonds. With the support of a qualified therapist near you, therapy creates a safe space to share, heal, and reconnect. Whether you're searching for therapy near me or counselling for your family, Phinity Therapy offers guidance for lasting change. Families are the foundation of our lives. They provide love, support, and connection, but they can also be the
Multiple Sclerosis Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Biogen, Immune Response BioPharma, Celgene, Novartis, Sanofi, Actelion, Bayer
Multiple Sclerosis Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Tri …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Acidosis

Metabolic Acidosis Pipeline Insight 2025: Exploring Next-Generation Therapies to …
DelveInsight's "Metabolic Acidosis - Pipeline Insight, 2025" report offers a comprehensive analysis of the evolving therapeutic landscape for metabolic acidosis, a serious electrolyte disorder characterized by excessive acid accumulation in the body due to renal, gastrointestinal, or respiratory dysfunction. With growing awareness and clinical need, the pipeline is witnessing progress in both early-stage and late-stage drug development aimed at restoring systemic pH balance and improving renal and cardiovascular outcomes. Current investigational
Metabolic Acidosis Market 2025: Key Trends, Applications, and Technological Adva …
The metabolic acidosis market is estimated to be valued at USD 177.9 Mn in 2024 and is expected to reach USD 265.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.89% from 2024 to 2031. According to the latest research from CoherentMI, the Metabolic Acidosis Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based on thorough
Renal Tubular Acidosis Market Expected to Experience Major Growth by 2034, Accor …
The Renal Tubular Acidosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Renal Tubular Acidosis pipeline products will significantly revolutionize the Renal Tubular Acidosis market dynamics. DelveInsight's "Renal Tubular Acidosis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Renal Tubular Acidosis, historical and forecasted epidemiology as well as the Renal Tubular
Distal Renal Tubular Acidosis (dRTA) Drugs Market Size, Share, Growth, Forecast …
Global Distal Renal Tubular Acidosis (dRTA) Drugs Market Set to Surge, Reaching US$ YY Million by 2031 The global distal renal tubular acidosis (dRTA) drugs market has exhibited remarkable growth, reaching US$ YY million in 2022, with projections indicating a robust expansion to US$ YY million by 2031. This upward trajectory reflects a steady Compound Annual Growth Rate (CAGR) of YY% during the forecast period from 2024 to 2031. dRTA, characterized by
Metabolic Acidosis Market to Grow at CAGR of 5.76% during 2024-2034
Market Overview: The metabolic acidosis market is expected to exhibit a CAGR of 5.76% during 2024-2034.The report offers a comprehensive analysis of the metabolic acidosis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions.
Metabolic Acidosis Market Report 2023-2033 | Industry Size, Analysis and Latest …
Market Overview: The 7 major metabolic acidosis markets are expected to exhibit a CAGR of 6% during 2023-2033. The report offers a comprehensive analysis of the metabolic acidosis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven